The researchers in Houston anticipate the final confirmation testing against antibiotics to be complete within a few weeks, predicated upon no problems with the quality and available quantity of vendor-supplied antibodies for the final bacteria in their test. Following that completion, the results of the research will be submitted to a peer-reviewed journal for publication. After that submittal has been completed, and prior to publication, a sensitivity confirmation study will be done by MDs and researchers who, in order to maintain objectivity in their research, were not part of the N-Assay development research. That study will be a relatively short study of potentially a month or two, and is essential for acceptance of the N-Assay for use as a diagnostic. "
This was put out about 2 months ago. How close are they getting the acceptance for N-Assay as a diagnostic ? A few weeks ?
Also, over 10 months since this was put out, where is any partners for N-Assay(V) at ? Do they have one by now ?
"NanoLogix facilities are not designed for work on viruses, for this specific project we are seeking a corporate partner with the facilities necessary to bring the new N-Assay (V) to the market as quickly as possible. We consider this a matter of national security and an emergency priority. We are in discussions with potential partners, positioned with strong ties to the US government, who understand the serious threat these viruses represent.”
In that same release in Feb 2012, this was put out talking about a $44 billion market.
"NanoLogix’s management is focused on positioning our BNP and BNF technology to enter and capture a significant portion of that market. We believe that businesses, and indeed whole industries, that need or supply diagnostics will choose our faster, simpler and cheaper technology over expensive, highly complex equipment that cannot differentiate between live active-threat and dead bacteria."
How much of that market did they capture to date ? I don't think much because the PPS wouldn't be where it is today if they had.
3 and half years later and what have they to show the shareholders ?? Doesn't sound like they have made millions upon million because this below was put out on this board not too long ago and does it sound like a company capturing significant portions of a $44 billion market ?
"That being said, it must be noted that if NanoLogix was a standard, well-financed company with millions of dollars in reserve, the work on the N-Assay and other products would have been fully funded by the company and the technology would potentially be a part of current market technology choices and ideally making a market impact as the BEST available diagnostic. As NanoLogix does not have that as a reserve, it takes longer to accomplish the same goal."
From the website ,Feb 2012, over 3 years ago,
After consultation with Broadridge, a provider of shareholder meeting services for corporations, NanoLogix determined that the total cost of a shareholder meeting, either real or virtual online, lies in the range of $30,000. That is in consideration of the fact that the company now has over 3,000 shareholders. Practically all funds spent by the company have to be raised via private stock placement. With vision towards investing in crucial steps including patent filings, FDA approval applications, and testing recent discoveries, NanoLogix is delaying its virtual shareholder meeting until after our technology receives FDA approval and an increased revenue stream has been established.
An increase revenue stream hasn't been established by now ?
"When's NNLX's Turn?
AQXP is exploding today...will NNLX ever do the same...wow just to have had 10k shares in that puppy would have made anyone verrrrry happy."
If you look at the past, NNLX did go over $1/share at one time when not long before that it was under a dime/share. I believe it will take more than hype to get it to do the same again. The company needs to show real progress and lately it hasn't been able to show it.
Zagendaizgud posted "You can't get it right."
A peer reviewed paper will be published either in 2014 or early 2015 detailing the actual studies with results and control data….."
It appears what didn't get right was when that peer reviewed paper would be published. Have you seen it ?
August 2013, 2 years ago….
"2. The N-Assay
Conceived in 2012 and currently under refinement, the N-Assay utilizes standard multiwell plates used in a unique method to deliver detection and identification of bacteria in frequently less than one hour. In tests at the University Of Texas Health Science Center at Houston (UTHSC- Houston), researchers have been able to reduce times for Group B Streptococcus and Gonorrhea from the traditional 48-72 hours to 30 minutes. Peer-reviewed papers are pending publication in medical scientific journals. Indications are that ANY bacteria for which an antibody exists will be detectable and identifiable through use of the N-Assay. NanoLogix is currently working with potential suppliers of select components for the assay in order to commercialize the test."
Anyone see those papers that were pending ?
"……..The company recently completed its own testing of FlatPack packaged TSA petri plates stored for 3 years in cold storage with E-coli 0157 H7 as the test bacteria and observed results similar to those of the third-party lab 2 year RT test for Anthrax. In a second test that was begun in June for determination of the stability of three different types of FlatPack-packaged agars under conditions conforming to MilSpec requirements for "Desert Hot" (to 60+ degrees Centigrade), the Flatpacks provided excellent agar protection and stability in simulated total power loss for periods of 24 hours, 7 days, and 30+ days, with culture results at all periods comparable to refrigerated and room temperature stored FlatPacks. The tests of NanoLogix FlatPacked plates were compared to plates furnished by competitors, with the competitors' plates performing adequately after 24 hours, but being completely desiccated and unusable by the 7-day point. A peer reviewed paper will be published either in 2014 or early 2015 detailing the actual studies with results and control data….."
It's the middle of August 2015, way past early 2015
The message boards are littered with outrageous predictions for this stock. And speaking of pumper-doctors, here is a prediction from giles_manley, the poster alias I believe for a guy Barnhizer subsequently recruited to be on the company's SAB, that was posted in Feb 2012:
"This is one technology, finally, that I am very familiar with. If I had to estimate, this company will be bought out somewhere in the next 1-3 years between $8-10/share. There is nothing even close on the market, and soon every pregnant woman will be tested using there technology, worldwide."
Looks like 3 years is here, see any thing near $8-10/share ? I'm seeing about 3 cents. Wonder what's going through that person's mind now ?
"Am I missing something...NNLX was a lock for $2 in Jan 2015."
It looks like it's Locked in at just a few cents at the moment. Lack of real significant news and sale numbers is what is missing. The company hasn't been able to produce those to show to the shareholders.
"The researchers in Houston anticipate the final confirmation testing against antibiotics to be complete within a few weeks, predicated upon no problems with the quality and available quantity of vendor-supplied antibodies for the final bacteria in their test. Following that completion, the results of the research will be submitted to a peer-reviewed journal for publication. After that submittal has been completed, and prior to publication, a sensitivity confirmation study will be done by MDs and researchers who, in order to maintain objectivity in their research, were not part of the N-Assay development research. That study will be a relatively short study of potentially a month or two, and is essential for acceptance of the N-Assay for use as a diagnostic.'
Weeks have past, has it been submitted yet ? Has that study started yet ?
"NanoLogix will distribute their products through Nasaem Al-Jazira in the Gulf Cooperation Council (GCC) area over a 5-year period. The GCC is comprised of Saudi Arabia, Kuwait, Bahrain, Oman, Qatar, and the United Arab Emirates. In a conservative estimate from a Saudi Arabian and GCC marketing expert based in Switzerland, the first year of sales for NanoLogix is projected to total $900,000 from this contract. The agreement provides the opportunity for expansion of the geographic area upon achievement of sales targets. NanoLogix projects the agreement will result in the hiring of additional production workers by summer 2014 with the ramp up in sales."
So how much has this yielded for the company ? Did they hire additional workers last summer ? Did sales ramp up ?
CoalPile wrote "I went over to sneak peek at the other board. Last post was july/10. The uber's must have found another board where they can pat the themselves on the back for their wise and astute investing."
They know where the PPS is at and reality has sunk in. The company hasn't done enough.
Couple years ago
"We have very competitive markets, and a good marketing plan that we are not sharing with anyone at present. We will not reveal how many of which product are being sold. Marketing Plan: manufacture BNF - BNP – Petrie Dishes and sell them! We have had multiple major corporations approach NanoLogix regarding distribution of our products, but the company is not ready to announce the plan until the independent peer-reviewed papers are published"
Seemed like the company had it all figured out back then didn't it ? Now couple years later does anyone see BNF being manufactured ? Does any one see any major corporation aiding in distribution ? Seriously it said "MULTIPLE", and they didn't get a one of them to help out ? Don't worry it's N-Assay to the rescue NOW and this time things are going be different ?? The market isn't acting like it thinks it will.
Ray from other board back in June
"Suggest you make a trip to Hubbard and report back. I'm simply stating imo the company is not capable filling any sustained large orders by itself. I have no problem with the products or there potential. You need to review staff, cash on hand, and distribution. The release of the company update/financials would help. imo
Sounds like someone who use to visit is saying some interesting stuff, hmm ?